Urological cancer, Malmö
211 – 220 of 563
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Reasons for Discontinuing Active Surveillance : Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium
- Contribution to journal › Article
-
Mark
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- Contribution to journal › Article
-
Mark
Proteogenomic characterization of patient-derived xenografts highlights the role of REST in neuroendocrine differentiation of castration-resistant prostate cancer
- Contribution to journal › Article
-
Mark
New Hope in Prostate Cancer Precision Medicine? miRNA Replacement and Epigenetics
- Contribution to journal › Debate/Note/Editorial
-
Mark
Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment : Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry
(2019) In European Urology Focus
- Contribution to journal › Article
-
Mark
The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
- Contribution to journal › Article
-
Mark
Hypertension associated neuroinflammation and cognitive decline are attenuated by targeting the sphingosine-1-phosphate pathway
- Contribution to journal › Published meeting abstract
-
Mark
The emerging alliance of sphingosine-1-phosphate signaling and immune cells: from basic mechanisms to implications in hypertension.
- Contribution to journal › Scientific review
-
Mark
Population-based, nationwide registration of prostatectomies in Sweden
- Contribution to journal › Article
-
Mark
The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia : An in vitro study
- Contribution to journal › Article
